Amneal Pharmaceuticals Of New York, LLC FDA Record

Warning letters, Form 483s, inspections, recalls and 510(k) clearances

  • Latest inspection NAI · Feb 3, 2020
  • 2 Class I recalls
  • No warning letters matched by name
Inspections 11 0 OAI
Recalls 27 2 Class I (7%)
Warning letters 0 None on file
510(k) clearances 0 None on file

Amneal Pharmaceuticals Of New York, LLC has 27 FDA recalls (2 Class I), 11 inspections, 0 510(k) clearances and 0 compliance actions on record. No FDA warning letter addressed to "Amneal Pharmaceuticals Of New York, LLC" is on file.

What these totals cover: FDA records filed under the name "Amneal Pharmaceuticals Of New York, LLC" and its spelling variant "Amneal Pharmaceuticals Of New York". Records filed under related names are not included; see Related names.

Latest recall
D-0873-2026 · Sep 8, 2026 · filed under Amneal Pharmaceuticals
Latest recall under this name
D-0868-2026 · Class II · Aug 28, 2026
Latest inspection
Feb 3, 2020 · NAI

Newer recall under related name Amneal Pharmaceuticals: Sep 8, 2026, D-0873-2026.

Summary

Record counts and when each FDA source was last refreshed
RecordsCountLast refreshedSource as ofStatus
Recalls27 (2 Class I)Nov 11, 2026 (checked Nov 15, 2026, unchanged)File dated Nov 10, 2026Current
510(k) clearances0Nov 15, 2026File dated Nov 9, 2026Current
Inspections11Nov 17, 2026Newest record Nov 9, 2026Current
Compliance actions0Nov 2, 2026Newest record Oct 29, 2026Current

FDA record by year

Amneal Pharmaceuticals Of New York, LLC's FDA inspections, warning letters and recalls in each of the last 10 calendar years (2017 to 2026, 2026 so far).

Amneal Pharmaceuticals Of New York, LLC: FDA inspections per year

2017: 1 inspection (0 OAI), 0 warning letters, 1 recall record (1 Class I) 2018: 0 inspections (0 OAI), 0 warning letters, 0 recall records (0 Class I) 2019: 1 inspection (0 OAI), 0 warning letters, 0 recall records (0 Class I) 2020: 1 inspection (0 OAI), 0 warning letters, 13 recall records (0 Class I) 2021: 0 inspections (0 OAI), 0 warning letters, 2 recall records (0 Class I) 2022: 0 inspections (0 OAI), 0 warning letters, 1 recall record (0 Class I) 2023: 0 inspections (0 OAI), 0 warning letters, 4 recall records (0 Class I) 2024: 0 inspections (0 OAI), 0 warning letters, 4 recall records (1 Class I) 2025: 0 inspections (0 OAI), 0 warning letters, 0 recall records (0 Class I) 2026: 0 inspections (0 OAI), 0 warning letters, 1 recall record (0 Class I)
YearInspectionsOAIWarning lettersRecall recordsClass I
202600010
202500000
202400041
202300040
202200010
202100020
2020100130
201910000
201800000
201710011

Inspections are counted by the date they ended, warning letters by the date FDA issued them and recall records by the recall start date. FDA lists one recall record per recalled product, so one recall event can add several.

Reviewing Amneal Pharmaceuticals Of New York, LLC as a supplier? Request a free FDA snapshot: name up to five suppliers and get a PDF of their public FDA record, with sources and dates. You do not need an API connection. Each snapshot is prepared by hand.

Check this supplier

Or check Amneal Pharmaceuticals Of New York, LLC yourself in Claude, Cursor or ChatGPT: get the full FDA risk summary, with inspections, warning letters, Form 483s and import alerts by site.

Get a free API key

Recent recalls

27 recall records from Aug 17, 2013 to Aug 28, 2026. Showing the 20 most recent. View all 27 recall records

NumberClassProductDate
D-0868-2026Class IIExenatide Injection, USP, 250 mcg/mL, 1.2 mL per prefilled pen, Rx Only, Subcutaneous Use Only, For…Aug 28, 2026
D-0477-2024Class IIMethylergonovine Maleate Tablets, USP, 0.2mg, 12-count bottle, Rx Only, Distributed by: Amneal…Mar 25, 2024
D-0442-2024Class IVancomycin Hydrochloride for Oral Solution, USP, 250 mg per 5 mL, packaged as (a) 80 mL bottle, NDC…Mar 21, 2024
D-0327-2024Class IIOseltamivir Phosphate for Oral Suspension 6mg/ml, 60 mL (reconstituted) bottle, RX only, Distributed…Feb 13, 2024
D-0319-2024Class IIPhenoxybenzamine Hydrochloride Capsules, USP 10mg, 100-count bottle, Rx only, Manufactured by…Jan 15, 2024
D-0426-2024Class IIDivalproex Sodium Extended-release Tablets, USP 250 mg, Rx Only, 100 tablets, Manufactured by…Dec 26, 2023
D-0090-2024Class IIExtended Phenytoin Sodium Capsules, USP, 100 mg, 100-count bottle, Distributed by Amneal…Oct 27, 2023
D-0876-2023Class IIExtended Phenytoin Sodium Capsules, USP, 100 mg, Rx Only, 100 capsules per bottle, Distributed by…May 30, 2023
D-0756-2023Class IIIMethylprednisolone Acetate Injectable Suspension, USP 80 mg/mL, For Intramuscular, Intrasynovial and…May 8, 2023
D-1362-2022Class IIDivalproex Sodium Extended Release Tablets, USP, 250 mg, packaged in 100-count bottle, Rx only…Jul 27, 2022
D-0233-2022Class IIFlocinolone Acetonide 0.01% Topical Oil, Body Oil, Rx, packaged in 4 oz. bottle, Distributed by…Nov 4, 2021
D-0234-2022Class IIFlocinolone Acetonide 0.01% Topical Oil, Scalp Oil, Rx, packaged in 4 oz. bottle, Distributed by…Nov 4, 2021
D-1348-2020Class IIamneal Metformin Hydrochloride Extended-Release Tablets, USP, 750 mg Rx only 100 Tablets bottles…May 29, 2020
D-1350-2020Class IIamneal Metformin Hydrochloride Extended-Release Tablets, USP, Bulk, Distributed by: Amneal…May 29, 2020
D-1352-2020Class IIamneal Metformin Hydrochloride Extended-Release Tablets, USP, 500 mg, 1000 tablets bottles…May 29, 2020
D-1393-2020Class IIamneal Metformin Hydrochloride Extended-Release Tablets, USP, 500 mg, 90 count bottle, Rx Only…May 29, 2020
D-1343-2020Class IIamneal Metformin Hydrochloride Extended-Release Tablets, USP, 500 mg, Rx Only, 100 count bottles…May 29, 2020
D-1353-2020Class IIamneal Metformin Hydrochloride Extended-Release Tablets, USP, 500 mg, 1000 tablets bottles…May 29, 2020
D-1354-2020Class IIamneal Metformin Hydrochloride Extended-Release Tablets, USP, Bulk, Rx Only, Distributed by: Amneal…May 29, 2020
D-1351-2020Class IIamneal Metformin Hydrochloride Extended-Release Tablets, 500 mg USP, 500 tablets bottles, Rx only…May 29, 2020

Recent FDA inspections

11 inspections from Aug 18, 2009 to Feb 3, 2020.

DateSiteProductClassificationFEI
Feb 3, 2020Hauppauge, NYDrugsNo Action Indicated (NAI)2434153
Mar 18, 2019Hauppauge, NYDrugsVoluntary Action Indicated (VAI)2434153
Apr 11, 2017Hauppauge, NYDrugsVoluntary Action Indicated (VAI)2434153
Aug 9, 2016Hauppauge, NYDrugsVoluntary Action Indicated (VAI)2434153
Mar 16, 2015Hauppauge, NYDrugsNo Action Indicated (NAI)2434153
Feb 7, 2014Hauppauge, NYDrugsVoluntary Action Indicated (VAI)2434153
May 15, 2012Hauppauge, NYDrugsVoluntary Action Indicated (VAI)2434153
Oct 29, 2010Hauppauge, NYDrugsNo Action Indicated (NAI)2434153
May 26, 2010Hauppauge, NYDrugsNo Action Indicated (NAI)2434153
Nov 24, 2009Hauppauge, NYDrugsVoluntary Action Indicated (VAI)2434153
Aug 18, 2009Hauppauge, NYDrugsVoluntary Action Indicated (VAI)2434153
NAI
No objectionable conditions or practices were found during the inspection.
VAI
Objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action.
OAI
Regulatory and/or administrative actions are recommended.

Look up the inspector observations behind these results with the FDA 483 search, or check for formal enforcement with the FDA warning letter search.

FDA-inspected facilities

1 inspected site, newest inspection first.

FacilityLocationInspectionsLatest
FEI 2434153Hauppauge, NY11Feb 3, 2020

Amneal Pharmaceuticals Of New York, LLC and the FDA: common questions

Has Amneal Pharmaceuticals Of New York, LLC received an FDA warning letter?

No FDA warning letter addressed to the name "Amneal Pharmaceuticals Of New York, LLC" is on file. This answer covers that name only: letters addressed to a related company name or to one of its sites are listed on that name's or site's own page.

Has Amneal Pharmaceuticals Of New York, LLC received an FDA Form 483?

FDA has not published a Form 483 for "Amneal Pharmaceuticals Of New York, LLC" in its reading room. FDA publishes some Form 483s, not all of them.

When did the FDA last inspect Amneal Pharmaceuticals Of New York, LLC?

The most recent FDA inspection on file ended Feb 3, 2020 at Hauppauge, NY and was classified NAI. FDA has 11 inspections of Amneal Pharmaceuticals Of New York, LLC on file.

Has Amneal Pharmaceuticals Of New York, LLC had an FDA recall?

Yes. Amneal Pharmaceuticals Of New York, LLC has 27 FDA recalls on record, 2 of them Class I, the most serious class. The most recent under this name started Aug 28, 2026. A newer recall, dated Sep 8, 2026, is filed under the related name Amneal Pharmaceuticals.

Need more than this page shows? Ask about Amneal Pharmaceuticals Of New York, LLC in Claude or ChatGPT and get every site's inspections, Form 483s, warning letters and import alerts, with a link to the FDA source for each record. The API key is free: no card.

Get a free API key

Prefer a PDF? Request a free supplier snapshot.

Is this your company or a supplier you list? Link to this FDA record from your site with a free button.

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.